HogansHero said: "Several of your premises are wrong but we are not wholly in disagreement.
Control and compliance are big IF's in your point. We have 2/3 of the country labelled persona non gratain New York. It is going to take a LOT of leadership change to fix that and we are 4 months away from even starting that process. I have been saying all along that the issue is not a vaccine per se but effective treatments. We are not that close that that either and it is unclear how long it might take for that critical mass to embrace that. Using Europe as an example is not very nourishing to your point: they are spiking and heading quickly back to heavier regulation. Where are these indoor theatres operating without density controls in Europe? Yes there are examples in Asia but (as I have also been saying here for months) Asia (or parts of it that is) is a horse of a different color,for a ton of reasons.
I am not seeing that much difference in your expectations and mine; you don't think this is a snap-your-finger type of solution. I don't however think you can separate the science and the economics and I think yu also expect more of the industry than it can deliver: it is a government issue, not an industry one. You can't market to people who will have to quarantine for 2 weeks when they get here. What the industry can and should be doing is fighting for public support. And when I say industry I don't really see the League at the forefront: its membership is, by and large, doing just fine. (And sad to say, but they are not that worried about the people who worked for them.) So when I read your projections, what I see is an industry that is going to start to come back next fall, and hopefully will be back to its new normalcy by the spring of '22.
I will leave you with the one word I have been preaching here since March or so: patience."
Nah, my premises are fine --- you've just misread or misconstrued them.
Of course control and compliance are big ifs. My point was that vaccine-less theater should be and indeed is possible, not that we're almost or already there. To the extent you may disagree about the possibility of it, I think you're really talking about the practicality of it. While you might argue that's not a useful distinction, I draw it because if we lose sight of the former, we won't be able to work on addressing the latter.
As for who the "we" is, I do see this as a public policy matter. I'm not sure where you are getting the idea that I am expecting too much of the industry, unless you think I'm wrong that the industry should be prepared to think outside the vaccine box and advocate for itself to policymakers. And I mentioned the League because it's the one that's been making these announcements about closures. That's given it --- and Charlotte St. Martin, who is constantly quoted in news articles --- a particularly prominent public profile that it has failed to use effectively during this crisis to speak up for the industry, which will eventually come back to bite the League's membership.
Please note also that Europe is more than just Spain and France. Germany, for example, had some theaters start to reopen at limited capacity in June, at which point its infection rate continued to dwindle or stay flat for a number of weeks. While its infection rate is now rising, it’s also rising here in New York, where we don’t have theaters open, which suggests these increases aren’t being driven by resumption of live indoor performances.